Our mission is to offer the first nasal influenza vaccine approved for children younger than 2 year that, in a natural way, provides double protection

Latest news

Highlights

Meet four people that contributed and pushed the company’s position forward towards it’s vision. Hear their story what Eurocine Vaccines has achieved during the year or read more about the success in our Annual Review 2017 =>

Listen to the Board Directors why they are engaged in the company and what thrills them about the technology of vaccination.

Calendar